DEMOGRAPHICS (Epidemiology Study)1999

Size: px
Start display at page:

Download "DEMOGRAPHICS (Epidemiology Study)1999"

Transcription

1 DEMOGRAPHICS (Epidemiology Study)1999 NOTE: All DATES will be recorded as MM / DD / YY and all TIMES will be recorded as MILITARY TIME. (D-1) Abstractor (D-2) / / Date of Initial Chart Review (D-3) : Time Abstraction Begun (D-4) : Time Ended (Codes for Type: 1=hospital 2=autopsy 3=outpatient clinic 4=physician 5=nursing home 6=squad record 9=N/A) (D-8) INSTITUTION Type Name: MR# (D-9) INSTITUTION Type Name: MR# (D-10) INSTITUTION Type Name: MR# (D-11) ICD-9-CM CODE (stroke related) (D-12) 1=primary 2=secondary 9=N/A (D-13) ICD Code, per Study Reviewer (D-14) NAME Enter 999 if no stroke-related code. Enter 999 if no stroke code. STUDY NO Last First Middle Initial (D-15) ADDRESS, Street City State Zip (D-16) PHONE ( ) - (D-17) SOCIAL SECURITY # - - (D-18) AGE (D-20) GENDER (D-21) ETHNIC GROUP (D-22) TYPE OF INSURANCE (D-23) MARITAL STATUS (D-19) DATE OF BIRTH / / 1=male 2=female (D-5) DATE OF STROKE (D-6) Date of Admission (D-7) Date of Discharge 1=Black 2=White 3=Hispanic 4=Asian 5=other (explain) 1=Medicare 2=Medicaid 3=HMO 4=other private /commercial 5=self pay / / / / / / If stroke happened at home when the subject was alone and was discovered later, enter the date discovered as the date of stroke. If unknown date but known month and year, enter month/15/year. If not a stroke or date not available, enter 06/15/88. 1=never married 2=married 3=living with partner 4=widowed 5=divorced 6=separated (D-24) EMPLOYMENT STATUS 1=currently employed 2=formerly employed 3=never employed 4=retired 7=homemaker (D-25) RESIDENCE AT TIME OF ADMISSION 1=home 2=nursing home 7=other (explain) (D-26) SITE WHERE STROKE OCCURRED 1=home 2=work 3=hospital 7=other (explain) (D-27) CASE 1=yes 2=no (D-28) Discussed with study PI 1=yes 2=no (D-29) Person determining status of case 1=abstractor 2=physician (D-30) TYPE OF CASE 1=infarct 2=TIA 3=ICH 4=SAH 5=IVH 6=unruptured cerebral aneurysm 7=other (explain) (D-31) REASON FOR EXCLUSION 1=out of time period 2=doesn t meet stroke criteria 3=residence out of geographic area 7=other (explain) 9=N/A (case) (D-32) INTERVIEWED 1=yes 2=no (D-33) Who was interviewed 1=patient only 2=proxy only 3=both patient and proxy 9=N/A (D-34) Reason interview not done 1=doctor refused permission 2=patient/family refused permission 3=non-case 4=not the interviewed case 5=greater than 60 days 6=patient expired 7=other (explain) (interview done) (D-35) Genetic material obtained using BUCCAL SWABS? 1=yes 2=no (D-36) Genetic material obtained using BLOOD? 1=yes 2=no (D-37) CASE PER PHYSICIAN REVIEW 1=yes 2=no (D-38) / / Date of physician review Enter 06/15/88 if N/A (D-39) Initials of MD (D-40) Type of Case, per Physician 1=infarct 2=TIA 3=ICH 4=SAH 5=IVH 6=unruptured cerebral aneurysm 7=other (explain) Date data entered Date Date completely into database incomplete / / revised, corrected / / entered into database / / 1

2 EMS RECORD (1) (EMS-1) Check here, if NO RECORD (EMS-2) EMS RUN 1=yes 2=no (EMS-3) TYPE OF RUN 1=ALS 2=BLS 8=unknown 9=not available (EMS-3a) Squad and Run Number INITIAL EVALUATION (EMS-4) / / (EMS-5) : Date Time (EMS-6) Awake prior to onset of stroke 1=yes 2=no TIMES (please use military time) 88:88=unk (EMS-7) : Dispatch (EMS-8) : At Scene (If no at scene time, use time of first vital signs.) (EMS-9) : To Hospital (EMS-10) : At Hospital (EMS-11) CHIEF 1=stroke/CVA 2=MI 3=seizure 4=fall /found down / unresponsive COMPLAINT 5=weakness / numbness 6=headache 7=other (explain) EVALUATION DONE (EMS-12) : Time (EMS-13) (EMS-14) (EMS-15) Blood Pressure Systolic Diastolic Pulse (EMS-16) Respirations For EMS-17 thru EMS-19, use (EMS-17) Eyes Glasgow Coma Scale (1-6) or (EMS-18) (EMS-19) Motor Verbal (EMS-20) Total 88=unk 99=N/A (EMS-21) Is GCS an estimate? 1=yes 2=no 2

3 EMS RECORD (2) LIFE SQUAD PROCEDURES (EMS-22) Check here, if NO RECORD (EMS-23) Monitor 1=yes 2=no (EMS-24) IV 1=yes 2=no (EMS-25) IV Fluid 1=NS 2=D5W 3=RL 4=hep lock (EMS-26) Rate (ml / hr or KVO, WO) 9=N/A 5=other 9=N/A (explain) (EMS-27) Oxygen 1=yes 2=no 9=N/A (EMS-28) L / min 9=N/A (EMS-29) D50 1=yes 2=no 9=N/A (EMS-30) Narcan 1=yes 2=no 9=N/A (EMS-31) Lidocaine 1=yes 2=no 9=N/A (EMS-32) B / P Medication 1=yes 2=no 9=N/A Type: (EMS-33) Intubation 1=yes 2=no 9=N/A (EMS-34) Glucose 1=yes 2=no 9=N/A (EMS-35) Pulse ox 1=yes 2=no 9=N/A (EMS-36) Other 1=yes 2=no (explain) 3

4 ED RECORD (1) (ED-1) Check here, if NO RECORD (ED-2) Hospital INITIAL EVALUATION (ED-3) Awake prior to onset 1=yes 2=no FIRST MEDICAL CONTACT (ED-4) Type (ED-5) / / Date (ED-6) : Time 1=911 2=PMD 3=NH 4=hospital 5=ED 6=coroner 7=other EVALUATION DATES / TIMES 06/15/88 for unknown dates, 88:88 for unknown times (ED-7) / / First Recorded ED (Arrival) Date (ED-8) : First Recorded ED (Arrival) Time (ED-9) : Time of 1st MD Order (ED-10) Sent to CT 1=yes 2=no (ED-11) / / Date Sent for CT (ED-12) : Time Sent for CT (ED-13) Disposition from ED 1=admit 2=discharged home 3=transfer to another hospital 4=coroner (ED-14) / / Date of Hospital Admit / Transfer (ED-15) : Time of Hospital Admit / Transfer (ED-16) / / Discharge Date Home (from ED) (ED-17) : Discharge Time Home (from ED) (ED-18) DIAGNOSIS FROM 1=stroke / CVA / TIA 2=MI 3=seizure 4=fall /found down / unresponsive ED CHART 5=weakness / numbness 6=headache / migraine 7=other (ED-19) CHIEF COMPLAINT, if other, above (ED-20) ADMITTING DIAGNOSIS, if other, above (ED-21) DISCHARGE DIAGNOSIS, if other, above 4

5 ED RECORD (2) SYMPTOMS (If not specified, chart 8=unk or 9=N/A) (ED-22) Weakness [if YES, answer ED-23, -24, -25] 1=yes 2=no 3=generalized (ED-23) Face 1=left 2=right 3=both (ED-24) Arm 1=left 2=right 3=both (ED-25) Leg 1=left 2=right 3=both (ED-26) Numbness [if YES, answer ED-27, -28, -29] 1=yes 2=no 3=generalized (ED-27) Face 1=left 2=right 3=both (ED-28) Arm 1=left 2=right 3=both (ED-29) Leg 1=left 2=right 3=both (ED-30) Headache 1=yes 2=no (ED-31) Mental Status 1=alert and oriented 2=drowsy / somnolent 3=dizzy 4=coma / unresponsive 5=posturing 6=alert but disoriented / confused 7=other (ED-32) Speech 1=normal 2=slurred 3=garbled 4=mute 7=other (ED-33) Fall / Cannot Walk 1=yes 2=no 9=N/A (ED-34) Vision 1=normal 2=blurred 3=double 4=partial loss 5=total blindness 6=photophobia 7=other (ED-35) Other (explain) 1=yes 2=no 9=N/A GLASGOW COMA SCORE (ED-36) Eyes (1 4) Glasgow Coma Scoring (1-6) or (ED-37) Motor (1 6) (ED-38) Verbal (1 5) (ED-39) Total 88=unk 99=N/A (ED-40) PU 1=yes 2=no 9=N/A (ED-41) Estimate? 1=yes 2=no 9=N/A (ED-42) NIH STROKE SCALE DONE? 1=yes 2=no (ED-43) If done, score (ED-44) ET PROCEDURES (ED-45) Arterial Line 99=N/A 1=yes 2=no 9=N/A 1=yes 2=no 9=N/A (ED-46) ANTIHYPERTENSIVE MEDICATION GIVEN (ED-47) (ED-48) Blood pressure Systolic Diastolic 1=yes 2=no 9=N/A If ED-46 is YES, answer ED-49 thru -54. If NO, slash mark blanks (ED-49) Medications Given (ED-50) : Time first dose administered (ED-51) Medications Given (ED-52) : Time first dose administered (ED-53) Medications Given (ED-54) : Time first dose administered 5

6 MEDICAL THERAPIES PRIOR TO ONSET OF STROKE (MED-0) Check here, if NO MEDICATIONS. List all medications. Their classification will be assigned at Stroke Research Center. MEDICATION (MED-1) (MED-2) (MED-3) (MED-4) (MED-5) (MED-6) (MED-7) (MED-8) (MED-9) (MED-10) (MED-11) (MED-12) (MED-13) (MED-14) (MED-15) (MED-16) (MED-17) (MED-18) (MED-19) (MED-20) (MED-21) (MED-22) (MED-23) (MED-24) (MED-25) (MED-26) (MED-27) (MED-28) CLASSIFICATION (MED-1a) (MED-2a) (MED-3a) (MED-4a) (MED-5a) (MED-6a) (MED-7a) (MED-8a) (MED-9a) (MED-10a) (MED-11a) (MED-12a) (MED-13a) (MED-14a) (MED-15a) (MED-16a) (MED-17a) (MED-18a) (MED-19a) (MED-20a) (MED-21a) (MED-22a) (MED-23a) (MED-24a) (MED-25a) (MED-26a) (MED-27a) (MED-28a) 6

7 STROKE EVALUATION (1) (SE-1) / / DATE OF STROKE If stroke happened at home when the subject was alone and was discovered later, enter the date discovered as the date of stroke. If unknown date but known month and year, enter month/15/year. (SE-2) : TIME OF STROKE 1=AM 2=PM 8=unk (SE-3) Was time of stroke estimated? 1=yes 2=no RULES FOR TIME OF STROKE ONSET: Enter exact time if given If reported as: Record as: After midnight 00:59 1=AM Morning 07:59 1=AM Afternoon 12:59 2=PM Evening 07:59 2=PM Don t know, Uncertain 88:88 8=unk (SE-4) EVALUATION DONE BY PHYSICIAN? 1=yes 2=no (SE-5) Place first of Evaluation 1=ER 2=OP setting 3=NH 4=ICU 5=floor 6=other (SE-6) / / Date (SE-7) : Time (SE-7a) / BP (if no ED record) (SE-8) CLINICAL CARDIAC EXAM 1=yes 2=no (SE-9) ER Physician Findings 1=normal 2=abnormal (SE-10) Admitting Physician Findings 1=normal 2=abnormal (SE-11) Arrhythmia 1=yes 2=no 8=unk If YES, explain (SE-12) Heart Murmur 1=yes 2=no If YES, type: 1=systolic 2=diastolic 3=both (SE-13) Neck Bruit 1=none 2=left 3=right 4=bilateral 7=other (SE-14) SEIZURE IN ACUTE SETTING OF STROKE 1=yes 2=no (SE-15) MODIFIED RANKIN SCALE PRIOR TO STROKE ONSET 0=no symptoms 1=no significant disability despite SXs; able to carry out usual activities 2=slight disabilities; unable to carry out all previous activities, but able to look after self without assistance 3=moderate disabilities; requiring some help; able to walk without assistance 4=moderately severe disabilities; unable to walk without assistance (includes cane, walker); unable to attend to body needs 5=severe disability; bedridden; incontinent; requiring constant nursing care 9=not available (SE-16) EVALUATED BY A NEUROLOGIST 1=yes 2=no (SE-17) Evaluated by someone other than a neurologist, identify: 1=neurosurgeon 2=PMD 3=ED MD (SE-18) NEUROLOGICAL FINDINGS 1=normal 2=abnormal (SE-19) Oriented to Person 1=yes 2=no (SE-20) Oriented to Place 1=yes 2=no (SE-21) Oriented to Time 1=yes 2=no 7

8 STROKE EVALUATION (2) (SE-22) NIH Stroke SCALE DONE? 1=yes 2=no (SE-23) If YES, total score. (SE-24) Abstracted stroke severity estimated below. 1=yes 2=no If unable to estimate, draw a slash thru SE-25 to SE-41. (SE-25) / / Date (SE-26) : Time NOTE: If not mentioned in record, code as normal. Use 8=unk and 9=N/A where applicable for the following: (SE-27) 1A Level of Consciousness 0=alert 1=drowsy 2=stuporous 3=coma (SE-28) 1B LOC Questions 0=answer both correctly 1=answers one correctly 2=answers neither correctly (SE-29) 1C LOC Commands 0=performs both correctly 1=performs one correctly 2=performs neither correctly (SE-30) 2 Best Gaze 0=normal 1=abnormal (SE-31) 3 Visual 0=normal 1=abnormal (SE-32) 4 Facial Palsy 0=normal 1=abnormal (SE-33) 5A Left Arm 0=normal 1=affected / weak 2=paralyzed / flaccid (SE-34) 5B Right Arm 0=normal 1=affected / weak 2=paralyzed / flaccid (SE-35) 6A Left Leg 0=normal 1=affected / weak 2=paralyzed / flaccid (SE-36) 6B Right Leg 0=normal 1=affected / weak 2=paralyzed / flaccid (SE-37) 7 Ataxia 0=normal 1=abnormal (SE-38) 8 Sensory 0=normal 1=abnormal (SE-39) 9 Best Language 0=normal 1=abnormal 2=mute (SE-40) 10 Dysarthria 0=normal 1=abnormal 2=speech incomprehensible (SE-41) 11 Neglect 0=normal 1=abnormal (SE-42) SHORT-TERM MEMORY PROBLEMS? 1=yes 2=no (SE-43) If YES, explain (SE-44) Did symptoms last more than 24 hours? 1=yes 2=no 3=wax and wane 4=Resolved PTA 5=intermittent (SE-44a) / Duration of Symptoms for TIA (hours / minutes) 7=other (SE-45) OTHER POSSIBLY PERTINENT NEUROLOGIC FINDINGS: (SE-46) NOTES: 8

9 STROKE (PRIOR) HISTORY (SH-1) PRIOR HISTORY OF STROKE 1=yes 2=no If NO, then draw a slash thru SH-2 to SH-7a. (SH-2) Number of prior strokes (SH-3) Significant impairment from prior strokes 1=yes 2=no PRIOR STROKES List most recent first Type of Stroke codes: 1=Cerebral Infarct 2=ICH 3=SAH 4=IVH (SH-4) Type of stroke (SH-5) Type of stroke (SH-6) Type of stroke (SH-7) Type of stroke (SH-4a) / / Date of Stroke (SH-5a) / / Date of Stroke (SH-6a) / / Date of Stroke (SH-7a) / / Date of Stroke PRIOR HISTORY OF: 1=yes 2=no (SH-8) Cerebral Aneurysm (SH-9) AVM (SH-10) TIA (SH-10a) / / Date of most recent TIA (SH-11) DEFICIT PRIOR TO STROKE NOT CAUSED BY A STROKE 1=yes 2=no (SH-12) If YES, specify 1=CVD 2=arthritis / bone disease 3=cancer 4=neurologic, other than stroke 5=respiratory 7=other FAMILY HISTORY Has any relative ever had: (SH-13) Ischemic Stroke 1=yes 2=no 8=unk (SH-14) Transient Ischemic Attack or mini Stroke 1=yes 2=no 8=unk (SH-15) Intracerebral Hemorrhage 1=yes 2=no 8=unk (SH-16) Subarachnoid Hemorrhage 1=yes 2=no 8=unk (SH-17) Stroke of unknown type 1=yes 2=no 8=unk (SH-18) Alzheimer s Disease or Dementia 1=yes 2=no 8=unk (SH-19) Brain Aneurysm 1=yes 2=no 8=unk (SH-20) Hypertension 1=yes 2=no 8=unk 9

10 BASELINE MEDICAL HISTORY (1) PRIOR TO STROKE ONSET Note: If no history of condition in record, then put 8=unk. (MHX-0) WEIGHT (LBS) / HEIGHT (FEET / INCHES) (MHX-1) HISTORY OF HYPERTENSION 1=yes 2=no 8=unk (MHX-2) Drug Treatment 1=yes 2=no 8=unk (MHX-3) DIABETES MELLITUS 1=yes 2=no 8=unk (MHX-4) Current or Past Treatment 1=yes 2=no 8=unk (MHX-5) If YES, type of treatment 1=diet only 2=oral med 3=insulin 8=unk (MHX-6) HISTORY OF ELEVATED CHOLESTEROL 1=yes 2=no 8=unk (MHX-7) If YES, type of treatment 1=diet 2=drug therapy 3=none 8=unk (MHX-8) HISTORY OF CORONARY ARTERY DISEASE 1=yes 2=no 8=unk (MHX-9) HISTORY OF MYOCARDIAL INFARCTION 1=yes 2=no 8=unk (MHX-10) / / If YES, date of most recent MI (MHX-11) ATRIAL FIBRILLATION BY EKG 1=yes 2=no 8=unk (MHX-12) HISTORY OF ANGINA 1=yes 2=no 8=unk (MHX-13) HISTORY OF CONGESTIVE HEART FAILURE 1=yes 2=no 8=unk (MHX-14) PROSTHETIC HEART VALVE 1=yes 2=no 8=unk (MHX-15) If YES, Type 1=mitral 2=aortic 3=both 8=unk (MHX-16) PRIOR CARDIAC BYPASS SURGERY 1=yes 2=no 8=unk (MHX-17) / / If YES, date of most recent surgery (MHX-18) CARDIAC VESSEL ANGIOPLASTY 1=yes 2=no 8=unk (MHX-19) / / If YES, date of most recent angioplasty (MHX-20) CARDIAC PACEMAKER 1=yes 2=no 8=unk (MHX-21) CARDIOMYOPATHY 1=yes 2=no 8=unk (MHX-22) HISTORY OF CAROTID ARTERY DISEASE 1=yes 2=no 8=unk (MHX-23) CAROTID ENDARTERECTOMY 1=yes 2=no 8=unk (MHX-24) / / If YES, date of most recent endarterectomy 10

11 BASELINE MEDICAL HISTORY (2) PRIOR TO STROKE ONSET (MHX-25) CEREBRAL ANGIOGRAM WITHIN 24 HRS PRIOR TO ONSET 1=yes 2=no 8=unk (MHX-26) CORONARY ANGIOGRAM WITHIN 24 HRS PRIOR TO ONSET 1=yes 2=no 8=unk (MHX-27) RECENT EMBOLI TO PERIPHERAL ARTERIES 1=yes 2=no 8=unk in last three months, to leg, arm, kidney, gut (MHX-28) DEMENTIA 1=yes 2=no 8=unk (MHX-28a) If YES, type 1=Alzheimer s 2=multi-infarct 7=other 8=unk (MHX-29) DEPRESSION 1=yes 2=no 8=unk (MHX-30) SICKLE CELL DISEASE 1=yes 2=no 8=unk (MHX-31) THALASSEMIA 1=yes 2=no 8=unk (MHX-32) HEMOPHILIA 1=yes 2=no 8=unk (MHX-33) HIV POSITIVE 1=yes 2=no 8=unk (MHX-34) HISTORY OF BRAIN TUMOR 1=yes 2=no 8=unk (MHX-35) If YES, type (MHX-36) HISTORY OF MALIGNANCY 1=yes 2=no 8=unk (MHX-37) If YES, type (MHX-38) HISTORY OF SEIZURE 1=yes 2=no 8=unk (MHX-39) OTHER SIGNIFICANT MEDICAL CONDITIONS 1=yes 2=no 8=unk If YES, list: (MHX-40) NOTES: 11

12 SUBSTANCE ABUSE (SA-1) SMOKING USE 1=yes 2=no 8=unk If NO or unknown, then draw a slash thru SA-2 to SA-5. (SA-2) Number of Years (SA-3) Number of Packs per Day 88=unk 99=N/A (SA-4) Current Smoker 1=yes 2=no (SA-5) How many years since last smoked? If current smoker, enter 99. If unknown, enter 88. (SA-6) RECENT ALCOHOL USE 1=yes 2=no 8=unk If NO or unknown, then draw a slash thru SA-7 and SA-8. (SA-7) Primary Type 1=beer 2=wine 3=hard liquor 7=other 8=unk (SA-8) Servings of Alcohol per Day or or Enter 0 servings if occasional use. Otherwise indicate the number of servings per day based on amounts below: 1 serving = 1 oz. hard liquor 1 serving = 4 oz. wine 1 serving = 12 oz. beer (SA-9) Patient noted on medical record as heavy drinker, defined as more than 2 servings per day 1=yes 2=no 8=unk STREET DRUG USE (SA-10) Marijuana 1=yes 2=no 8=unk (SA-11) Hashish 1=yes 2=no 8=unk (SA-12) Cocaine / Crack 1=yes 2=no 8=unk (SA-13) Speed 1=yes 2=no 8=unk (SA-14) LSD 1=yes 2=no 8=unk (SA-15) Ecstasy 1=yes 2=no 8=unk (SA-16) Heroin 1=yes 2=no 8=unk (SA-17) Methadone 1=yes 2=no 8=unk (SA-18) ICE 1=yes 2=no 8=unk (SA-19) PCP 1=yes 2=no 8=unk (SA-20) Inhalants 1=yes 2=no 8=unk (SA-21) Other 1=yes 2=no 8=unk Specify: (SA-22) ALCOHOL DETECTED IN URINE OR BLOOD 1=yes 2=no 8=unk (SA-23) DRUGS (other than alcohol) DETECTED IN URINE OR BLOOD 1=yes 2=no 8=unk (SA-24) STREET DRUG USE WITHIN 24 HOURS OF STROKE ONSET 1=yes 2=no 8=unk (SA-25) NOTES: 12

13 ADMISSION EKG, CHEST X-RAY (EKG-1) Check here, if NO RECORD (EKG-2) ADMISSION EKG 1=normal 2=abnormal If ABNORMAL, answer EKG-3 thru EKG-11 (EKG-3) Sinus Bradycardia < 60 1=yes 2=no (EKG-4) Sinus Tachycardia > 100 1=yes 2=no (EKG-5) PAC (Atrial Ectopics) 1=yes 2=no (EKG-6) PVC (Ventricular Ectopic) 1=yes 2=no (EKG-7) Atrial Fibrillation / Flutter 1=yes 2=no (EKG-8) 3rd Degree Heart Block 1=yes 2=no (EKG-9) LVH (Estes of 4+ on report) 1=yes 2=no (EKG-10) Old MI (listed on interpretation) 1=yes 2=no (EKG-11) Acute MI (must list acute MI, not just ischemic changes) 1=yes 2=no (EKG-12) ATRIAL FIBRILLATION DEVELOPED LATER IN STAY l=yes 2=no (EKG-13) CHEST X-RAY l=normal 2=abnormal (EKG-14) NOTES: 13

14 DIAGNOSTIC TESTS (DIA-1) CT OF HEAD DONE AFTER ONSET 1=yes 2=no (DIA-2) Location of Study Performed (DIA-3) / / Date of Study (DIA-4) : Time of Study (DIA-5) Primary Findings 1=normal 2=infarct 3=ICH 4=SAH 5=AVM 6=aneurysm 7=other (DIA-6) CT Notes: (DIA-7) SECOND CT DONE 1=yes 2=no (DIA-8) Location of Study Performed (DIA-9) / / Date of Study (DIA-10) : Time of Study (DIA-11) Primary Findings 1=normal 2=infarct 3=ICH 4=SAH 5=AVM 6=aneurysm 7=other (DIA-12) 2nd CT Notes: (DIA-13) MR DONE 1=yes 2=no (DIA-14) Location of Study Performed (DIA-15) / / Date of Study (DIA-16) : Time of Study (DIA-17) Primary Findings 1=normal 2=infarct 3=ICH 4=SAH 5=AVM 6=aneurysm 7=other (DIA-18) MR Notes: (DIA-19) SECOND MR DONE 1=yes 2=no (DIA-20) Location of Study Performed (DIA-21) / / Date of Study (DIA-22) : Time of Study (DIA-23) Primary Findings 1=normal 2=infarct 3=ICH 4=SAH 5=AVM 6=aneurysm 7=other (DIA-24) 2nd MR Notes: (DIA-25) NOTES: 14

15 LABORATORY (LAB-1) Check here, if NO RECORD (LAB-2) LOCATION OF LAB (LAB-3) / / DATE DRAWN (Put slash mark, if not available) (LAB-4). White Blood Cell Count (LAB-5). Hemoglobin (LAB-6) Platelet Count (in thousands) (LAB-7). Creatinine (LAB-8) Serum Blood Sugar Lipid Profile (LAB-9) LDL (LAB-10) HDL (LAB-11). LDL / HDL (LAB-12) Triglycerides (LAB-13) Total Cholesterol (LAB-14). Protime (LAB-15). INR (LAB-16). Partial Thromboplastin Time (LAB-17) Anticardiolipin Antibodies 1=normal 2=abnormal 8=unk (LAB-18) Lumbar Puncture 1=yes 2=no 8=unk If YES, answer LAB-19 and LAB-20 (LAB-19) LP RBCs (LAB-20) Xanthochromia 1=yes 2=no 8=unk (LAB-21) Positive RPR or VDRL 1=yes 2=no 8=unk (LAB-22) (LAB-23) (LAB-24) CK CKMB SED Rate (LAB-25) OTHER: 15

16 MR ANGIOGRAPHY (MR-1) Check here, if NO RECORD (MR-2) MR ANGIOGRAPHY DONE 1=yes 2=no (MR-3) (MR-4) LOCATION / / DATE (MR-5) : TIME (MR-6) FINDINGS 1=normal 2=abnormal TO BE COMPLETED BY PHYSICIAN (MR-7) Source of information 1=film 2=report 3=both (MR-8) (MR-9) If ABNORMAL, answer MR-8 thru MR-22 1=occluded / absent 2=severe stenosis 3=possible stenosis 8=not examined 9=N/A CCA right CCA left (MR-10) ICA neck right (MR-11) ICA neck left (MR-12) ICA siphon right (MR-13) ICA siphon left (MR-14) MCA right trunk (MR-15) MCA left trunk (MR-16) ACA right trunk (MR-17) ACA left trunk (MR-18) PCA right trunk (MR-19) PCA left trunk (MR-20) Vertebral right (MR-21) Vertebral left (MR-22) Basilar (MR-23) ANEURYSM 1=yes 2=no If YES, answer MR-24 thru MR-32 (MR-24) ICA 1=left 2=right 3=both 4=not seen 9=N/A (MR-25) ACOM 1=left 2=right 3=both 4=not seen 9=N/A (MR-26) Ophthalmic 1=left 2=right 3=both 4=not seen 9=N/A (MR-27) PCOM 1=left 2=right 3=both 4=not seen 9=N/A (MR-28) ACA 1=left 2=right 3=both 4=not seen 9=N/A (MR-29) MCA 1=left 2=right 3=both 4=not seen 9=N/A (MR-30) Vertebral 1=left 2=right 3=both 4=not seen 9=N/A (MR-31) Basilar 1=yes 4=not seen 9=N/A (MR-32) AVM 1=yes 4=not seen 9=N/A (MR-33) OTHER: 16

17 CEREBRAL ANGIOGRAPHY (CR-1) Check here, if NO RECORD (CR-2) CEREBRAL ANGIOGRAPHY DONE 1=yes 2=no (CR-3) (CR-4) LOCATION / / DATE (CR-5) : TIME (CR-6) FINDINGS 1=normal 2=abnormal TO BE COMPLETED BY PHYSICIAN (CR-7) Source of information 1=film 2=report 3=both (CR-8) (CR-9) If ABNORMAL, answer CR-8 thru CR-30 1=no lesion 2=mild, <50% 3=moderate, 50-79% 4=severe, 80-99% 5=occlusion 8=not examined 9=N/A CCA right CCA left (CR-10) ICA neck right (CR-11) ICA neck left (CR-12) ICA siphon right (CR-13) ICA siphon left (CR-14) MCA right trunk (CR-15) MCA left trunk (CR-16) MCA right branch (CR-17) MCA left branch (CR-18) ACA right trunk (CR-19) ACA left trunk (CR-31) ANEURYSM 1=yes 2=no If YES, answer CR-32 thru CR-40 (location and size of largest diameter) Codes for location: 1=left 2=right 3=both 4=not seen 9=N/A location size (mm) (CR-32) ICA (CR-33) ACOM (CR-34) Ophthalmic (CR-35) PCOM (CR-36) ACA (CR-37) MCA (CR-38) Vertebral (CR-39) PICA (CR-40) Basilar (1=yes) (CR-41) AVM 1=yes 4=not seen 9=N/A (CR-20) ACA right branch (CR-21) ACA left branch (CR-22) PCA right trunk (CR-23) PCA left trunk (CR-24) PCA right branch (CR-25) PCA left branch (CR-26) Vertebral right (CR-27) Vertebral left (CR-28) PICA right (CR-29) PICA left (CR-30) Basilar (CR-42) OTHER: 17

18 CAROTID ULTRA (CA-1) Check here, if NO RECORD (CA-2) Carotid ultrasound done after stroke 1=yes 2=no If YES, complete the rest of this form. (CA-3) / / DATE (CA-4) : TIME (CA-5) Carotid Findings 1=normal 2=abnormal If ABNORMAL, complete the following: RIGHT LEFT (CA-6) CCA 1=no lesion 2=mild <50% 3=mod 50-79% 4=severe 80-99% 5=occlusion 8=not VIS (CA-7) ICA 1=no lesion 2=mild <50% 3=mod 50-79% 4=severe 80-99% 5=occlusion 8=not VIS (CA-8) ECA 1=no lesion 2=mild <50% 3=mod 50-79% 4=severe 80-99% 5=occlusion 8=not VIS 9=N/A 9=N/A 9=N/A (CA-9) Ulceration 1=yes 2=no If YES, complete the following: RIGHT LEFT (CA-10) CCA 1=yes 2=no (CA-11) ICA 1=yes 2=no (CA-12) NOTES: 18

19 ECHO (EC-1) Check here, if NO RECORD (EC-2) Echocardiogram 1=yes 2=no 8=unk If YES, answer the following: (EC-3) / / Date of Echocardiogram (EC-4) Type of Echocardiogram 1=transthoracic (TTE) 2=transesophageal (TEE) 3= 1&2 8=unk If both TTE and TEE, use TEE data to complete rest of form. (EC-5) Quality of Study 1=adequate 2=poor 3= limited 8=unk (EC-6) Echocardiographic Findings 1=normal 2=abnormal 8=unk (EC-7) Left atrial enlargement 1=yes 2=no 8=unk (EC-8) LVH 1=yes 2=no 8=unk (EC-9) VALVULAR VEGETATION 1=yes 2=no 8=unk (EC-10) CARDIOMYOPATHY 1=yes 2=no 8=unk (EC-11) MURAL THROMBUS 1=yes 2=no 8=unk (EC-12) MVP 1=yes 2=no 8=unk (EC-13) AKINETIC WALL 1=yes 2=no 8=unk (EC-14) VENTRICULAR ANEURYSM 1=yes 2=no 8=unk (EC-15) LV EJECTION FRACTION 1=yes 2=no 8=unk If YES, % (EC-16) SPONTANEOUS LEFT ATRIAL CONTRAST OR SMOKE 1=yes 2=no 8=unk (EC-17) MITRAL VALVULAR DISEASE, NOT MVP 1=yes 2=no 8=unk (EC-18) AORTIC VALVE DISEASE 1=yes 2=no 8=unk (EC-19) PATENT FORAMEN OVALE 1=yes 2=no 8=unk (EC-20) ATRIAL SEPTAL ANEURYSM 1=yes 2=no 8=unk (EC-21) AORTIC ATHEROSCLEROTIC DEBRIS 1=yes 2=no 8=unk (Plaques of ascending aorta & aortic arch) (EC-22) OTHER 1=yes 2=no 8=unk If YES, specify: (EC-23) NOTES: 19

20 INTERVENTIONS (IT-1) Check here, if NO RECORD (IT-2) MAJOR OPERATIONS 1=yes 2=no If YES, answer IT-3 thru IT-5 (IT-3) / / Date of Operation (IT-4) : Time of Operation (IT-5) Type of Operation 1=aneurysm clipping 2=clot evacuation 3=AVM resection 5=other (IT-6) INTRACRANIAL PRESSURE MONITORING 1=yes 2=no (IT-7) INTUBATION 1=yes 2=no (IT-8) INTRAVENTRICULAR DRAIN or SHUNT PLACED 1=yes 2=no (IT-9) NIPRIDE FOR BLOOD PRESSURE CONTROL 1=yes 2=no (IT-10) OTHER MEDICATION FOR BLOOD PRESSURE CONTROL 1=yes 2=no (IT-11) If YES, specify: (IT-12) / BLOOD PRESSURE (closest to 24 hours after admission) (IT-13) MANNITOL FOR INCREASED ICP 1=yes 2=no (IT-14) HYPERVENTILATION FOR INCREASED ICP 1=yes 2=no (IT-15) THROMBOLYTIC THERAPY 1=yes 2=no (IT-16) HEPARIN FOLLOWING ISCHEMIC STROKE 1=yes 2=no (IT- 16a) if YES, date / / and time : of start (IT-17) NIMODIPINE FOLLOWING SAH 1=yes 2=no (IT-18) OTHER EXPERIMENTAL DRUG STUDY 1=yes 2=no (IT-19) If YES, specify: (IT-20) MEDICAL TREATMENT FOR STOKE PREVENTION AFTER STROKE 1=yes 2=no 9=N/A If YES, answer questions IT-21 thru IT-29 (IT-21) Aspirin, < 325 mg/day 1=yes 2=no (IT-22) Aspirin, = 325 mg/day 1=yes 2=no (IT-23) Aspirin, > 325 mg/day 1=yes 2=no (IT-24) Warfarin 1=yes 2=no (IT-25) Ticlopidine 1=yes 2=no (IT-26) Persantine 1=yes 2=no (IT-27) Clopidogrel (Plavix) 1=yes 2=no (IT-28) Other 1=yes 2=no (IT-29) If other, specify (IT-30) NOTES: 20

21 CLINICAL COURSE (CC-1) Check here, if NO RECORD NOTE: If there are questions regarding whether a subsequent event is a new event or a continuation of an old event, contact the physician. (CC-2) SUBSEQUENT STROKE OF SAME TYPE 1=yes 2=no (CC-3) If NO, draw a slash thru CC-3 and CC-4. / / Date (CC-4) Type 1=infarct 2=TIA 3=ICH 4=SAH (CC-5) SUBSEQUENT STROKE OF DIFFERENT TYPE 1=yes 2=no NOTE: IF YES (and stroke is not TIA), THIS STROKE MUST BE ABSTRACTED SEPARATELY. If NO, draw a slash thru CC-6 and CC-7. (CC-6) / / Date (CC-7) Type 1=infarct 2=TIA 3=ICH 4=SAH (CC-7a) HEMORRHAGIC TRANSFORMATION 1=yes 2=no Please describe in the NOTES field, below. (CC-7b) / / Date (CC-8) ANGIOGRAPHIC VASOSPASM 1=yes 2=no (as documented by angiogram) (CC-9) VASOSPASM BY ELEVATED VELOCITIES 1=yes 2=no on Transcranial Doppler, as noted on record (CC-10) REBLEEDING/HEMORRHAGE GROWTH BY CT 1=yes 2=no (CC-10a) INFARCT FOLLOWING HEM./SAME EVENT 1=yes 2=no (CC-11) HYDROCEPHALUS BY CT OR MR 1=yes 2=no (CC-12) NOTES: 21

22 OUTCOME (O-1) VITAL STATUS AT DISCHARGE 1=dead 2=alive (O-2) / / If DEAD, Date of Death (O-3) Cause of Death 1=herniation 2=rebleed 3=vasospasm 4=cardiac arrhythmia 5=MI 6=CHF 7=other 8=unk 9=N/A 10=sudden, unexplained 11=pneumonia 12=pulmonary embolism 13=not clear If ALIVE, answer O-4 to O-7: FUNCTIONAL STATUS at 30 days post stroke or discharge. (O-4) / / DATE MODIFIED RANKIN DONE (O-5) Modified Rankin 0=no symptoms 1=no significant disability despite SXs; able to carry out usual activities 2=slight disabilities; unable to carry out all previous activities, but able to look after self without assistance 3=moderate disabilities; requiring some help; able to walk without assistance 4=moderately severe disabilities; unable to walk without assistance (includes cane, walker); unable to attend to body needs 5=severe disability; bedridden; incontinent; requiring constant nursing care 9=not available (O-6) / / DATE OXFORD HANDICAP SCALE DONE (O-7) Oxford Handicap Scale 0=no symptoms 1=minor symptoms that do not interfere with lifestyle 2=minor handicap, symptoms that lead to some restriction in lifestyle, but do not interfere with the patient s capacity to look after himself 3=moderate handicap, symptoms that significantly restrict lifestyle and prevent totally independent existence 4=moderately severe handicap, symptoms that clearly prevent independent existence, though not needing constant attention 5=severe handicap, totally dependent patient requiring constant attention night and day 9=not available (O-8) / / DATE OF DISCHARGE (O-9) DISPOSITION AT DISCHARGE 1=Home (alone, or with others) 2=Relative or friend 3=Rehab Hospital 4=Skilled Nursing Facility 5=Extended care 6=Hospital 7 =other (specify) 8=unknown 9=N/A IF DISCHARGED TO PLACE OTHER THAN HOME: (O-10) Name: (O-11) Address: (O-12) City/ST/Zip: (O-13) Phone: ( ) - (O-14) / / DATE OF LAST VISIT / LAST TIME SEEN 22

23 AUTOPSY (AU-1) Check here, if patient is alive and has NO RECORD (AU-2) / / DATE OF DEATH (m/d/y) (AU-3) AUTOPSY DONE? 1=yes 2=no If YES, answer the following: (AU-4) / / Date of Autopsy (AU-5) Heart Weight (grams) (AU-6) Type of Stroke Causing Death 1=SAH 2=ICH 3=infarct 4=SAH & ICH 5=ICH & IVH 6=IVH 7=other (AU-7) IF SAH, CAUSE OF SAH 1=aneurysm 2=AVM 3=other (AU-8) IF ICH, CAUSE OF ICH 1=small vessel hypertension 2=amyloid 3=AVM 4=tumor 5=aneurysm 7=other 12=vasculitis 13=blood dyscrasia 14=anticoagulants 15=thrombolytic agents (AU-9) IF INFARCT, CAUSE OF INFARCT 1=small vessel disease 2=cardioembolism 3=atheroembolism 4= large vessel occlusion 5=vasculitis 7=other 8= unk 9=N/A (AU-10) OTHER PERTINENT FINDINGS (e.g., aneurysm, AVM, old strokes, atherosclerosis of intra- or extracranial vessels): 23

24 CTs and MRs CT #1 CT #2 MR #1 MR #2 (CTMR-1) DATE / / / / / / / / (CTMR-2) TIME : : : : (CTMR-3) (CTMR-4) Source of Data Number of Brain Lesions Seen FINDINGS 1=film only 2=report only 3=both 4=neither (CTMR-5) Edema } 1=yes (CTMR-6) Mass Effect } 2=no (CTMR-7) Midline Shift } 8=unk (CTMR-8) (CTMR-9) (CTMR-10) Hydrocephalus (not due to atrophy) Periventricular Leukomalacia Number of slices where white matter changes are visualized } 9=N/A 1=mild 2=mod 3=sev 4=none (CTMR-11) Slice Thickness (mm) (CTMR-12) SAH Present? 1=yes 2=no (CTMR-13) If YES, Fisher classification (range 1-4) (CTMR-14) IVH Present? 1=yes 2=no (CTMR-15) If YES, Petruk classification (range 0-3) (CTMR-16) Evidence of rebleeding since earliest scan 1=yes 2=no (CTMR-17) Notes for CT #1 (CTMR-18) Notes for CT #2 (CTMR-19) Notes for MR #1 (CTMR-20) Notes for MR #2 24

25 CT #1 LESIONS Complete the following for up to 4 lesions. #1 lesion should be that lesion most likely related to clinical history and neurological findings. (CTL1-1) Does this lesion explain the 1=yes 2=no 3=possible clinical findings? (CTL1-2) Lesion Type 1=infarct 2=ICH If INFARCT: (CTL1-3) Age 1 = 0-30 days 2 = >30 days (CTL1-4) Category 1=bland 2=hemorrhage 3=other Lesion #1 Lesion #2 Lesion #3 Lesion #4 (CTL1-5) If OTHER, specify (CTL1-6) Location 1=subcortical 2=watershed 3=cortical 4=1&3 5=brain stem 6=cerebellum If ICH: (CTL1-7) IVH also present 1=yes 2=no (CTL1-8) SAH also present 1=yes 2=no Anatomic Location: 1=right 2=left 3=midline (CTL1-9) Frontal.. (CTL1-10) Temporal.. (CTL1-11) Parietal.. (CTL1-12) Occipital.. (CTL1-13) Deep White Matter.. (CTL1-14) Putamen.. (CTL1-15) Globus Pallidus.. (CTL1-16) Internal Capsule.. (CTL1-17) Thalamus.. (CTL1-18) Caudate.. (CTL1-19) Pons.. (CTL1-20) Midbrain.. (CTL1-21) Cerebellum.. (CTL1-22) Vascular Distribution 1=ICA 2=MCA 3=ACA 4=PCA 5=MCA branch 6=ACA branch 7=PCA branch 8=leticullstriate 12=basilar artery 13=penetrating basilar 14=PICA 9=Art of Heubner 15=AICA 16=SCA (CTL1-30) Notes for Lesion # =thalamo-perf 17=cort medul art artery 11=anterior 88=unk choroidal 99=N/A Size of Infarct/Hemorrhage: (CTL1-23) Largest Diameter (cm)... (CTL1-24) Diameter 90 Degrees to Largest (cm) (CTL1-25) On Number of 10mm Slices... (CTL1-26) Ellipsoid Volume.. (CTL1-27) Notes for Lesion #1 (CTL1-28) Notes for Lesion #2 (CTL1-29) Notes for Lesion #3

26 CT #2 LESIONS Complete the following for up to 4 lesions. #1 lesion should be that lesion most likely related to clinical history and neurological findings. (CTL2-1) Does this lesion explain the 1=yes 2=no 3=possible clinical findings? (CTL2-2) Lesion Type 1=infarct 2=ICH If INFARCT: (CTL2-3) Age 1 = 0-30 days 2 = >30 days (CTL2-4) Category 1=bland 2=hemorrhage 3=other Lesion #1 Lesion #2 Lesion #3 Lesion #4 (CTL2-5) If OTHER, specify (CTL2-6) Location 1=subcortical 2=watershed 3=cortical 4=1&3 5=brain stem 6=cerebellum If ICH: (CTL2-7) IVH also present 1=yes 2=no (CTL2-8) SAH also present 1=yes 2=no Anatomic Location: 1=right 2=left 3=midline (CTL2-9) Frontal.. (CTL2-10) Temporal.. (CTL2-11) Parietal.. (CTL2-12) Occipital.. (CTL2-13) Deep White Matter.. (CTL2-14) Putamen.. (CTL2-15) Globus Pallidus.. (CTL2-16) Internal Capsule.. (CTL2-17) Thalamus.. (CTL2-18) Caudate.. (CTL2-19) Pons.. (CTL2-20) Midbrain.. (CTL2-21) Cerebellum.. (CTL2-22) Vascular Distribution 1=ICA 2=MCA 3=ACA 4=PCA 5=MCA branch 6=ACA branch 7=PCA branch 8=leticullstriate 12=basilar artery 13=penetrating basilar 14=PICA 9=Art of Heubner 15=AICA 16=SCA (CTL2-30) Notes for Lesion # =thalamo-perf 17=cort medul art artery 11=anterior 88=unk choroidal 99=N/A Size of Infarct/Hemorrhage: (CTL2-23) Largest Diameter (cm)... (CTL2-24) Diameter 90 Degrees to Largest (cm) (CTL2-25) On Number of 10mm Slices... (CTL2-26) Ellipsoid Volume.. (CTL2-27) Notes for Lesion #1 (CTL2-28) Notes for Lesion #2 (CTL2-29) Notes for Lesion #3

27 MR #1 LESIONS Complete the following for up to 4 lesions. #1 lesion should be that lesion most likely related to clinical history and neurological findings. (MRL1-1) Does this lesion explain the 1=yes 2=no 3=possible clinical findings? (MRL1-2) Lesion Type 1=infarct 2=ICH If INFARCT: (MRL1-3) Age 1 = 0-30 days 2 = >30 days (MRL1-4) Category 1=bland 2=hemorrhage 3=other Lesion #1 Lesion #2 Lesion #3 Lesion #4 (MRL1-5) If OTHER, specify (MRL1-6) Location 1=subcortical 2=watershed 3=cortical 4=1&3 5=brain stem 6=cerebellum If ICH: (MRL1-7) IVH also present 1=yes 2=no (MRL1-8) SAH also present 1=yes 2=no Anatomic Location: 1=right 2=left 3=midline (MRL1-9) Frontal.. (MRL1-10) Temporal.. (MRL1-11) Parietal.. (MRL1-12) Occipital.. (MRL1-13) Deep White Matter.. (MRL1-14) Putamen.. (MRL1-15) Globus Pallidus.. (MRL1-16) Internal Capsule.. (MRL1-17) Thalamus.. (MRL1-18) Caudate.. (MRL1-19) Pons.. (MRL1-20) Midbrain.. (MRL1-21) Cerebellum.. (MRL1-22) Vascular Distribution 1=ICA 2=MCA 3=ACA 4=PCA 5=MCA branch 6=ACA branch 7=PCA branch 8=leticullstriate 12=basilar artery 13=penetrating basilar 14=PICA 9=Art of Heubner 15=AICA 16=SCA (MRL1-30) Notes for Lesion # =thalamo-perf 17=cort medul art artery 11=anterior 88=unk choroidal 99=N/A Size of Infarct/Hemorrhage: (MRL1-23) Largest Diameter (cm)... (MRL1-24) Diameter 90 Degrees to Largest (cm) (MRL1-25) On Number of 10mm Slices... (MRL1-26) Ellipsoid Volume.. (MRL1-27) Notes for Lesion #1 (MRL1-28) Notes for Lesion #2 (MRL1-29) Notes for Lesion #3

28 MR #2 LESIONS Complete the following for up to 4 lesions. #1 lesion should be that lesion most likely related to clinical history and neurological findings. (MRL2-1) Does this lesion explain the 1=yes 2=no 3=possible clinical findings? (MRL2-2) Lesion Type 1=infarct 2=ICH If INFARCT: (MRL2-3) Age 1 = 0-30 days 2 = >30 days (MRL2-4) Category 1=bland 2=hemorrhage 3=other Lesion #1 Lesion #2 Lesion #3 Lesion #4 (MRL2-5) If OTHER, specify (MRL2-6) Location 1=subcortical 2=watershed 3=cortical 4=1&3 5=brain stem 6=cerebellum If ICH: (MRL2-7) IVH also present 1=yes 2=no (MRL2-8) SAH also present 1=yes 2=no Anatomic Location: 1=right 2=left 3=midline (MRL2-9) Frontal.. (MRL2-10) Temporal.. (MRL2-11) Parietal.. (MRL2-12) Occipital.. (MRL2-13) Deep White Matter.. (MRL2-14) Putamen.. (MRL2-15) Globus Pallidus.. (MRL2-16) Internal Capsule.. (MRL2-17) Thalamus.. (MRL2-18) Caudate.. (MRL2-19) Pons.. (MRL2-20) Midbrain.. (MRL2-21) Cerebellum.. (MRL2-22) Vascular Distribution 1=ICA 2=MCA 3=ACA 4=PCA 5=MCA branch 6=ACA branch 7=PCA branch 8=leticullstriate 12=basilar artery 13=penetrating basilar 14=PICA 9=Art of Heubner 15=AICA 16=SCA (MRL2-30) Notes for Lesion # =thalamo-perf 17=cort medul art artery 11=anterior 88=unk choroidal 99=N/A Size of Infarct/Hemorrhage: (MRL2-23) Largest Diameter (cm)... (MRL2-24) Diameter 90 Degrees to Largest (cm) (MRL2-25) On Number of 10mm Slices... (MRL2-26) Ellipsoid Volume.. (MRL2-27) Notes for Lesion #1 (MRL2-28) Notes for Lesion #2 (MRL2-29) Notes for Lesion #3

29 STROKE SUBTYPE (1) (STR-1) NURSE S IMPRESSION OF STROKE SUBTYPE 1=infarct 2=TIA 3=ICH 4=SAH 5=ICH SAH 6=IVH (STR-2) Notes: (STR-3) PHYSICIAN S FINAL IMPRESSION OF STROKE SUBTYPE 1=infarct 2=TIA 3=ICH 4=SAH 5=ICH+SAH 6=IVH If subtype is INFARCT or TIA, suspected cause: (STR-4) SMALL VESSEL OCCLUSIVE DISEASE 1=Brain images show deep infarct <= 1.5 cm appropriate to the clinical syndrome present, which is typical lacunar, e.g., pure motor hemiparesis face; arm & leg; or arm & leg relatively. 2=Clinical syndrome as above, but CT is negative for lesion that could explain the syndrome. 3=Brain images show deep infarct <= 1.5 cm that could explain the clinical syndrome, but it is other than the classically described lacunar strokes. 4=not seen 8=unk 9=N/A (STR-5) CARDIOEMBOLIC STROKE 1= yes 2=no If NO, unk, or N/A, then slash thru STR-6 to STR-15. (STR-6) Atrial fibrillation or flutter 1= yes 2=no (STR-7) MI within 2 months 1= yes 2=no (STR-8) Cardiac thrombus on testing 1= yes 2=no (STR-9) Valvular vegetation 1= yes 2=no (STR-10) Prosthetic heart valve 1= yes 2=no (STR-11) Acute congestive heart failure 1= yes 2=no (STR-12) Dilated cardiomyopathy 1= yes 2=no (STR-13) Right to left shunt with venous source 1= yes 2=no (STR-14) Systemic emboli related to cardiac source (within 3 months) 1= yes 2=no (STR-15) Akinetic segment on echo or other cardiac testing 1= yes 2=no 29

30 STROKE SUBTYPE (2) (STR-16) LARGE VESSEL ATHEROSCLEROSIS 1=Evidence from angiogram or non-invasive tests of > 50% area stenosis of occlusion consistent with atherosclerosis of an artery appropriate to the site of the infarct, e.g. common carotid, proximal internal carotid, carotid siphon, middle cerebral, basilar and distal vertebral arteries without evidence for distal emboli to explain infarct. 2=Same as (1), but with evidence for distal emboli to explain infarct. 3=Tandem Lesion Strokes Evidence of stenosis or distal occlusion of a large intracranial artery supplying the infarcted area with an ipsilateral proximal lesion of at least 50% stenosis or evidence for an ulcerated plaque. 4=not seen 8=unk 9=N/A (STR-17) STROKE WITH NORMAL ARTERIES (normal angiogram) 1= yes 2=no 3=no ANGIO (STR-18) OTHER IDENTIFIED CAUSE OF ISCHEMIC STROKE 1= yes 2=no (STR-19) If YES, specify: (STR-20) UNKNOWN CAUSE OF INFARCT 1= yes 2=no (STR-21) LIKELIEST CLINICAL CLASSIFICATION OF ISCHEMIC STROKE 1=small vessel 2=cardioembolic 3=large vessel 4=normal artery 5=other ident (STR-22) If subtype is ICH, most likely cause: 1=sm vessel HTN 2=amyloid 3=AVM 4=cavern hemang 5=aneurysm 6=tumor 7=thrombolytics 8=anticoagulants 9=cocaine 10=other 11=no clear cause 88=unk 99=N/A (STR-23) If OTHER, specify: (STR-24) Location 1=deep 2=lobar 3=brain stem 4=cerebellum (STR-25) If subtype is SAH, most likely cause: 1=aneurysm 2=AVM 3=vasculitis 4=no clear cause (STR-26) / / Date of Physician Review (STR-27) Reviewer Initials (STR-28) NOTES: 30

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

DEMOGRAPHICS (Epidemiology Study) 2005

DEMOGRAPHICS (Epidemiology Study) 2005 DEMOGRAPHICS (Epidemiology Study) 2005 NOTE: (D-1) (D-2) All DATES will be recorded as MM / DD / YY, and all TIMES will be recorded as MILITARY TIME. Abstractor / / Date of Chart Completion STUDY NO (D-6)

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal

More information

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one: MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL 2014-15 The following is a list of variables and how to complete each one: (PHY-1) Case, per physician review: The most important task for the physicians

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates

More information

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment

More information

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke

More information

Cryptogenic Strokes: Evaluation and Management

Cryptogenic Strokes: Evaluation and Management Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

PATIENT S NOTES History and Physical Brain Attack Stroke

PATIENT S NOTES History and Physical Brain Attack Stroke UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES History and Physical Brain Attack Stroke 040527.01 page 1 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No Date and Time: Current inpatient

More information

GWTG Post-Discharge Follow-up Form

GWTG Post-Discharge Follow-up Form Bold font = Required field Patient ID: Date of Hospital Admission: / / mm / dd / yyyy Date Follow-up Completed: / / mm / dd / yyyy PATIENT LOGISTICS Method used for Patient follow-up: Chart Review Health

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

<INSERT COUNTRY/SITE NAME> All Stroke Events

<INSERT COUNTRY/SITE NAME> All Stroke Events WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke

More information

CVA. Alison Atwater PA-C

CVA. Alison Atwater PA-C CVA Alison Atwater PA-C Types of CVAs Ischemic strokes 80% of strokes 2/3 are thrombotic 1/3 are embolic emboli from the heart or arteries feeding the brain such as carotids, vertebral and basilar etc

More information

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Chapter 15 Introduction Cardiovascular disease (CVD) is the leading cause of death in the U.S. One American dies from CVD every 33 seconds Nearly half of all Americans will die from

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

ACCESS CENTER:

ACCESS CENTER: ACCESS CENTER: 1-877-367-8855 Emergency Specialty Services: BRAIN ATTACK Criteria: Stroke symptom onset time less than 6 hours Referring Emergency Department Patient Information Data: Time last known normal:

More information

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11 Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as

More information

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

TENNESSEE STROKE REGISTRY QUARTERLY REPORT TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 3 September 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender

More information

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists Shawke A. Soueidan, MD Riverside Neurology & Sleep Specialists 757-221-0110 Epidemiology of stroke 2018 Affects nearly 800,000 people in the US annually Approximately 600000 first-ever strokes and 185000

More information

Stroke Transfer Checklist

Stroke Transfer Checklist Stroke Transfer Checklist When preparing to transfer an acute stroke patient to the UF Health Shands Comprehensive Stroke Center, please make every attempt to include the following information: Results

More information

Disclosure Statement: Dr. Knoefel has nothing to disclose

Disclosure Statement: Dr. Knoefel has nothing to disclose Stroke Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico Geriatrics/Extended Care (retired) New Mexico VA Healthcare System Albuquerque, NM Disclosure Statement: Dr.

More information

The Muscatine Study Heart Health Survey

The Muscatine Study Heart Health Survey The Muscatine Study Heart Health Survey PARTICIPANT ID LABEL (include study ID, name, DOB, gender) Today s Date: - - (MM-DD-YYYY) Thank you for agreeing to participate in the International Childhood Cardiovascular

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination pulse 80/min reg, BP 160/95

More information

INTRODUCTORY TEXT BOX

INTRODUCTORY TEXT BOX INTRODUCTORY TEXT BOX Diagnostic Partners provides a range of onsite, in-office cardiac and vascular diagnostic testing services. From Resting Echocardiograms to Abdominal Aorta scans, each study is performed

More information

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II 14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Cerebrovascular Disease

Cerebrovascular Disease Neuropathology lecture series Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O 2 consumption (resting):

More information

Basilar artery stenosis with bilateral cerebellar strokes on coumadin

Basilar artery stenosis with bilateral cerebellar strokes on coumadin Qaisar A. Shah, MD Patient Profile 68 years old female with a history of; Basilar artery stenosis with bilateral cerebellar strokes on coumadin Diabetes mellitus Hyperlipidemia Hypertension She developed

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014 ND STROKE Coordinators Case Studies STEMI and Stroke Conference, Fargo, ND, August 5, 2014 STROKE Coordinator Case Study Essentia Health, Fargo Essentia Health Stroke Alert Process Within 24 hours of Last

More information

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center Pre-Hospital Stroke Care: Bringing It To The Street by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center Overview/Objectives Explain the reasons or rational behind the importance

More information

North Oaks Trauma Symposium Friday, November 3, 2017

North Oaks Trauma Symposium Friday, November 3, 2017 Traumatic Intracranial Hemorrhage Aaron C. Sigler, DO, MS Neurosurgery Tulane Neurosciences None Disclosures Overview Anatomy Epidural hematoma Subdural hematoma Cerebral contusions Outline Traumatic ICH

More information

Neurosurgical Management of Stroke

Neurosurgical Management of Stroke Overview Hemorrhagic Stroke Ischemic Stroke Aneurysmal Subarachnoid hemorrhage Neurosurgical Management of Stroke Jesse Liu, MD Instructor, Neurological Surgery Initial management In hospital management

More information

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012 Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management

More information

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with Non-fluent dysphasia R facial weakness Background Ischaemic heart disease Hypertension Hyperlipidemia L MCA branch

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

GERIATRICS CASE PRESENTATION

GERIATRICS CASE PRESENTATION GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone

More information

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement

More information

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow Neuropathology lecture series III. Neuropathology of Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O

More information

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian Stroke in the ED Dr. William Whiteley Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian 2016 RCP Guideline for Stroke RCP guidelines for acute ischaemic stroke

More information

E X P L A I N I N G STROKE

E X P L A I N I N G STROKE EXPLAINING STROKE Introduction Explaining Stroke is a practical step-by-step booklet that explains how a stroke happens, different types of stroke and how to prevent a stroke. Many people think a stroke

More information

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among

More information

Subarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style.

Subarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style. Subarachnoid Hemorrhage (SAH) William J. Jones, M.D. Assistant Professor of Neurology Co-Director, UCH Stroke Program Click to edit Master title style Disclosures/Relationships No conflicts of interest

More information

Blood Supply. Allen Chung, class of 2013

Blood Supply. Allen Chung, class of 2013 Blood Supply Allen Chung, class of 2013 Objectives Understand the importance of the cerebral circulation. Understand stroke and the types of vascular problems that cause it. Understand ischemic penumbra

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

TCD AND VASOSPASM SAH

TCD AND VASOSPASM SAH CURRENT TREATMENT FOR CEREBRAL ANEURYSMS TCD AND VASOSPASM SAH Michigan Sonographers Society 2 Nd Annual Fall Vascular Conference Larry N. Raber RVT-RDMS Clinical Manager General Ultrasound-Neurovascular

More information

Stroke Awareness. Presented by: Duane Anderson, MD Snoqualmie Valley Hospital Emergency Department Medical Director

Stroke Awareness. Presented by: Duane Anderson, MD Snoqualmie Valley Hospital Emergency Department Medical Director Stroke Awareness Presented by: Duane Anderson, MD Snoqualmie Valley Hospital Emergency Department Medical Director What is a stroke? Stroke can happen to anyone. Stroke is the fourth leading cause of death

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

BY: Ramon Medina EMT-LP/RN

BY: Ramon Medina EMT-LP/RN BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management

More information

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD Cerebral Vascular Diseases Nabila Hamdi MD, PhD Outline I. Stroke statistics II. Cerebral circulation III. Clinical symptoms of stroke IV. Pathogenesis of cerebral infarcts (Stroke) 1. Ischemic - Thrombotic

More information

57y WRH woman, controlled HTN only, presents with sudden LOC, fixed and dilated, quadraplegic Intubated on arrival and CT is negative CTA and CTP

57y WRH woman, controlled HTN only, presents with sudden LOC, fixed and dilated, quadraplegic Intubated on arrival and CT is negative CTA and CTP Case # 1 Hx 57y WRH woman, controlled HTN only, presents with sudden LOC, fixed and dilated, quadraplegic Intubated on arrival and CT is negative CTA and CTP show left PCA occlusion, some basilar stenosis,

More information

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018 Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy

More information

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012 Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model

More information

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco I have no financial disclosures 1 Hospital Management Thrombolytic and Thrombectomy Blood pressure Stroke in the Young

More information

Cerebrovascular Disease

Cerebrovascular Disease Cerebrovascular Disease I. INTRODUCTION Cerebrovascular disease (CVD) includes all disorders in which an area of the brain is transiently or permanently affected by ischemia or bleeding and one or more

More information

ACUTE CENTRAL PERIFERALEMBOLISM

ACUTE CENTRAL PERIFERALEMBOLISM EAE TEACHING COURSE 2010 Belgrade, Serbia October 22-23, 2010 ACUTE CENTRAL and PERIFERALEMBOLISM Maria João Andrade Lisbon, PT BACKGROUND Stroke is a leading cause of mortality and long-term disability

More information

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer: When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation

More information

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man Stroke Topics Advances in the Prevention and Treatment of Stroke August 10, 2009 John W. Engstrom, M.D. Professor of Neurology Acute treatment options for ischemic stroke tpa, clot retraction, future directions

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to

More information

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine Hypertensive Haemorrhagic Stroke Dr Philip Lam Thuon Mine Intracerebral Haemorrhage Primary ICH Spontaneous rupture of small vessels damaged by HBP Basal ganglia, thalamus, pons and cerebellum Amyloid

More information

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018 Stroke Stroke Megan Stevens MD Vascular Neurology SUDDEN Maximal at onset Lateralized weakness, lateralized numbness, vision loss (one eye or portion of field in both eyes), double vision, slurred speech,

More information

TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION

TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION ---Rune Aaslid First TCD Publication 1982 WHAT IS TCD? Uses 2 MHz pulsed Doppler ultrasound Passes through cranial windows Provides information

More information

ANNUAL FOLLOW-UP FORM

ANNUAL FOLLOW-UP FORM Public reporting burden for this collection of information is estimated to average 6-15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and

More information

HAAD quality KPI; waiting time

HAAD quality KPI; waiting time Type: Waiting Time Indicator Indicator Number: WT001 Primary Care Appointment- Outpatient Setting Time to see a HAAD licensed family physician or member of their team (GP) Time of request (walk-in or by

More information

TIA: Updates and Management 2008

TIA: Updates and Management 2008 TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE Objectives Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE Recognize the clinical signs of acute stroke Differentiate between stroke and some of the more common stroke mimics Review

More information

STROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

STROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to: STROKE INTRODUCTION Stroke is the medical term for a specific type of neurological event that causes damage to the brain. There are two types of stroke, but both types of stroke cause the same type of

More information

Identifying Cerebrovascular Disorders. Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine

Identifying Cerebrovascular Disorders. Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine Identifying Cerebrovascular Disorders Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine Objectives Review different types of cerebrovascular disorders. Briefly discuss etiology,

More information

Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY

Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY Disclosures None Part A. Objectives Epidemiology of AIS and of ELVO Concept: Acute Ischemic

More information

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed

More information

DIFFERENT STROKES FOR DIFFERENT FOLKS!!

DIFFERENT STROKES FOR DIFFERENT FOLKS!! DIFFERENT STROKES FOR DIFFERENT FOLKS!! Identifying Stroke Subtypes SWAROOP PAWAR M.D., MPH. Vascular Neurologist UMG Neuroscience Associates Greenville Health System None Disclosures Outline Stroke, TIA

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

More information

Comparison of Five Major Recent Endovascular Treatment Trials

Comparison of Five Major Recent Endovascular Treatment Trials Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline

More information

NEURO IMAGING 2. Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity

NEURO IMAGING 2. Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity NEURO IMAGING 2 Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity I. EPIDURAL HEMATOMA (EDH) LOCATION Seventy to seventy-five percent occur in temporoparietal region. CAUSE Most likely caused

More information

Practical Considerations in the Early Treatment of Acute Stroke

Practical Considerations in the Early Treatment of Acute Stroke Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant

More information

IDPH EMS Region Five. Stroke Education

IDPH EMS Region Five. Stroke Education IDPH EMS Region Five Stroke Education Time is Brain!!!!! Time is Brain!!!! Stroke refers to any spontaneous damage to the brain caused by an abnormality of the blood supply by means of a clot or bleed.

More information

What Do You Think of My Posterior?

What Do You Think of My Posterior? What Do You Think of My Posterior? Posterior Stroke and Stroke Mimics Peter Panagos, MD, FACEP, FAHA Associate Professor Emergency Medicine and Neurology Washington University School of Medicine Disclosures

More information

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Patient Details Time of onset? Capillary Blood glucose 2.8-22.2 mmol/l? Blood

More information

Acute Coronary Syndrome

Acute Coronary Syndrome ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

More information

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate? Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University

More information

PFO Management update

PFO Management update PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

Surgical Management of Stroke Brandon Evans, MD Department of Neurosurgery

Surgical Management of Stroke Brandon Evans, MD Department of Neurosurgery Surgical Management of Stroke Brandon Evans, MD Department of Neurosurgery 2 Stroke Stroke kills almost 130,000 Americans each year. - Third cause of all deaths in Arkansas. - Death Rate is highest in

More information

Interventions in the Management of Acute Stroke. Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital

Interventions in the Management of Acute Stroke. Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital Interventions in the Management of Acute Stroke Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital Acute stroke intervention Number of stroke patients increasing day by

More information

Abdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm.

Abdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm. Glossary of Terms Abdominal Exam: The examination of the abdomen used by physicians to detect an abdominal aortic aneurysm. Angiogram: A diagnostic test requiring the insertion of a catheter into an artery

More information